KORU Medical Systems, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KRMD research report →
About the company
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems.
- CEO
- Linda Tharby
- IPO
- 1994
- Employees
- 80
- HQ
- Mahwah, NY, US
Price Chart
- Market Cap
- $206.24M
- P/E
- -91.26
- P/S
- 4.77
- P/B
- 12.30
- EV/EBITDA
- -136.98
- Div Yield
- 0.00%
- Gross Margin
- 61.47%
- Op Margin
- -5.99%
- Net Margin
- -5.27%
- ROE
- -13.61%
- ROIC
- -12.78%
- Revenue
- $41.13M · 22.23%
- Net Income
- $-2,637,926 · 56.52%
- EPS
- $-0.06 · 56.08%
- Op Income
- $-2,972,442
- FCF YoY
- 70.93%
- 52W High
- $6.61
- 52W Low
- $2.91
- 50D MA
- $4.07
- 200D MA
- $4.58
- Beta
- 0.42
- Avg Volume
- 145.17K
Get TickerSpark's AI analysis on KRMD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 26 | KALBERMATTEN ADAM R | other | 286,697 |
| Jul 1, 26 | WHOLIHAN EDWARD | other | 3,571 |
| Jul 1, 26 | Matin Shahriar | other | 3,571 |
| Jul 1, 26 | French Donna | other | 3,571 |
| Jul 1, 26 | FLETCHER R JOHN | other | 5,357 |
| Jul 1, 26 | CASCELLA ROBERT | other | 3,571 |
| Jun 30, 26 | Manko Joseph M. Jr. | other | 3,571 |
| Jun 11, 26 | KALBERMATTEN ADAM R | buy | 7,500 |
| Jun 11, 26 | KALBERMATTEN ADAM R | buy | 5,000 |
| May 18, 26 | Schiller Eric | buy | 5,000 |
Our KRMD coverage
Recent articles, reports, and earnings notes.
No research on KRMD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KRMD report →Similar companies
Peers in the same neighborhood.